Guanhao Biotech Co Ltd (300238) — Strategic Asset Allocation Index
Guanhao Biotech Co Ltd (300238) has a Strategic Asset Allocation Index of 46.4% as of June 2023. Strategic assets (PP&E of CN¥214.29 Million plus long-term investments of CN¥-) total CN¥214.29 Million, measured against net assets of CN¥462.30 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Guanhao Biotech Co Ltd (300238) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Guanhao Biotech Co Ltd Strategic Asset Allocation Index (2008–2021)
This chart shows how Guanhao Biotech Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2008 to 2021. As of June 2023, the index stands at 46.4%, representing strategic assets of CN¥214.29 Million against net assets of CN¥462.30 Million CNY. For live market cap and overall valuation, see Guanhao Biotech Co Ltd (300238) market capitalisation.
Annual Strategic Asset Allocation Index for Guanhao Biotech Co Ltd (2008–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Guanhao Biotech Co Ltd from 2008 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Guanhao Biotech Co Ltd for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 32.8% | CN¥245.54 Million | CN¥245.54 Million | CN¥- | CN¥748.16 Million | ▲ +2.0 pp |
| 2020 | 30.8% | CN¥220.63 Million | CN¥220.63 Million | CN¥- | CN¥716.66 Million | ▼ -2.8 pp |
| 2019 | 33.6% | CN¥236.51 Million | CN¥236.51 Million | CN¥- | CN¥704.14 Million | ▲ +11.5 pp |
| 2018 | 22.1% | CN¥254.88 Million | CN¥254.88 Million | CN¥- | CN¥1.16 Billion | ▼ -0.3 pp |
| 2017 | 22.4% | CN¥271.42 Million | CN¥271.42 Million | CN¥- | CN¥1.21 Billion | ▲ +8.1 pp |
| 2016 | 14.2% | CN¥207.64 Million | CN¥207.64 Million | CN¥- | CN¥1.46 Billion | ▼ -18.8 pp |
| 2015 | 33.1% | CN¥205.30 Million | CN¥205.30 Million | CN¥- | CN¥620.62 Million | ▼ -6.9 pp |
| 2014 | 40.0% | CN¥212.39 Million | CN¥212.39 Million | CN¥- | CN¥531.61 Million | ▼ -5.6 pp |
| 2013 | 45.6% | CN¥227.03 Million | CN¥227.03 Million | CN¥- | CN¥498.16 Million | ▼ -3.5 pp |
| 2012 | 49.1% | CN¥222.76 Million | CN¥222.76 Million | CN¥- | CN¥454.11 Million | ▲ +18.1 pp |
| 2011 | 31.0% | CN¥134.10 Million | CN¥134.10 Million | CN¥- | CN¥432.79 Million | ▼ -31.6 pp |
| 2010 | 62.6% | CN¥90.79 Million | CN¥90.79 Million | CN¥- | CN¥144.99 Million | ▲ +27.9 pp |
| 2009 | 34.7% | CN¥26.71 Million | CN¥26.71 Million | CN¥- | CN¥76.95 Million | ▲ +23.1 pp |
| 2008 | 11.6% | CN¥4.30 Million | CN¥4.30 Million | CN¥- | CN¥37.01 Million | — |